Metformin stimulates FGF21 expression in primary hepatocytes.

Metformin stimulates FGF21 expression in primary hepatocytes.
复制标题

DOI:
10.1155/2012/465282
复制
发表时间:
2012
影响因子:
--
通讯作者:
Andersen B
Andersen B
中科院分区:
其他
文献类型:
--
作者:
Nygaard EB;Vienberg SG;Ørskov C;Hansen HS;Andersen B

文献摘要

参考文献

被引文献

相似文献

成纤维细胞生长因子21(FGF21)是一种新型的糖脂代谢调节剂;然而,FGF21 的确切作用和调节机制尚不完全清楚。代谢状态在 FGF21 的调节中起着重要作用,因此我们检查了二甲双胍(一种间接 AMPK 激活剂)是否调节肝细胞中的 FGF21 表达。将原代培养的大鼠和人肝细胞与二甲双胍一起孵育24小时后测定FGF21 mRNA和蛋白表达。为了研究 AMPK 在 FGF21 假定调节中的作用,在二甲双胍存在的情况下将肝细胞与化合物 C(一种 AMPK 抑制剂)一起孵育。在用二甲双胍处理的大鼠和人肝细胞中观察到 FGF21 表达的强烈剂量依赖性增加。通过添加 AMPK 抑制剂化合物 C 可以阻断这种作用。研究表明二甲双胍是肝 FGF21 表达的有效诱导剂,并且二甲双胍的作用似乎是通过 AMPK 激活介导的。由于 FGF21 疗法可使 2 型糖尿病动物模型的血糖正常化,二甲双胍诱导肝脏 FGF21 可能在二甲双胍的抗糖尿病作用中发挥重要作用。
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator of glucose and lipid metabolism; however, the exact mechanism of action and regulation of FGF21 is not fully understood. Metabolic status plays an important role in the regulation of FGF21, and we therefore examined whether metformin, an indirect AMPK-activator, regulates FGF21 expression in hepatocytes. FGF21 mRNA and protein expression were determined after incubation of primary cultured rat and human hepatocytes with metformin for 24 hours. To study the role of AMPK in the putative regulation of FGF21, hepatocytes were incubated with Compound C (an AMPK inhibitor) in the presence of metformin. A strong dose-dependent increase in FGF21 expression was observed in both rat and human hepatocytes treated with metformin. This effect was blocked by addition of the AMPK-inhibitor Compound C. The study shows that metformin is a potent inducer of hepatic FGF21 expression and that the effect of metformin seems to be mediated through AMPK activation. As FGF21 therapy normalizes blood glucose in animal models of type 2 diabetes, the induction of hepatic FGF21 by metformin might play an important role in metformin's antidiabetic effect.
DOI: 10.1016/j.bbrc.2007.06.068
发表时间: 2007-08-24
影响因子: 3.1
作者:
Lundasen, Thomas;Hunt, Mary C.;Rudling, Mats
通讯作者: Rudling, Mats
DOI: 10.2337/db11-0846
发表时间: 2012-04
期刊: Diabetes
影响因子: 7.7
作者:
Li H;Gao Z;Zhang J;Ye X;Xu A;Ye J;Jia W
通讯作者: Jia W
正常受试者和新诊断 2 型糖尿病患者的循环 FGF-21 水平
DOI: 10.1055/s-2007-985148
发表时间: 2008-01-01
影响因子: 1.8
作者:
Chen, W. -W.;Li, L.;Boden, G.
通讯作者: Boden, G.
DOI: 10.1016/j.cmet.2007.05.002
发表时间: 2007-06-01
期刊: CELL METABOLISM
影响因子: 29
作者:
Badman, Michael K.;Pissios, Pavlos;Maratos-Flier, Eleftheria
通讯作者: Maratos-Flier, Eleftheria
DOI: 10.1073/pnas.1006962107
发表时间: 2010-07-13
影响因子: 11.1
作者:
Chau, Mary D. L.;Gao, Jiaping;Gromada, Jesper
通讯作者: Gromada, Jesper